v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Jan. 31, 2023         3,837,560      
Balance (Accounting Standards Update 2016-13 [Member]) at Jan. 31, 2023 $ 0 $ 0 $ 36,000 $ 36,000        
Balance at Jan. 31, 2023         $ 38,000 $ 132,511,000 $ (97,038,000) $ 35,511,000
Restricted stock issued (in shares)         129,849      
Restricted stock issued         $ 1,000 (1,000) 0 0
Restricted stock forfeited (in shares)         (25,233)      
Restricted stock forfeited         $ 0 0 0 0
Surrender of stock (in shares)         (12,730)      
Surrender of stock         $ 0 (280,000) 0 (280,000)
Issuance of common stock (in shares)         0      
Issuance of common stock         $ 0 0 0 0
Exercise of warrants (in shares)         0      
Exercise of warrants         $ 0 0 0 0
Warrant reclassification         0 0 0 0
Share-based compensation expense         0 2,244,000 0 2,244,000
Net loss         $ 0 0 (18,697,000) (18,697,000) [1]
Balance (in shares) at Jan. 31, 2024         3,929,446      
Balance at Jan. 31, 2024         $ 39,000 134,474,000 (115,699,000) 18,814,000
Restricted stock issued (in shares)         249,570      
Restricted stock issued         $ 3,000 (3,000) 0 0
Restricted stock forfeited (in shares)         (31,709)      
Restricted stock forfeited         $ 0 0 0 0
Surrender of stock (in shares)         (13,644)      
Surrender of stock         $ 0 (81,000) 0 (81,000)
Issuance of common stock (in shares)         123,502      
Issuance of common stock         $ 1,000 769,000 0 770,000
Exercise of warrants (in shares)         7,317      
Exercise of warrants         $ 0 0 0 0
Warrant reclassification         0 837,000 0 837,000
Share-based compensation expense         0 2,100,000 0 2,100,000
Net loss         0 0 (10,159,000) (10,159,000) [1]
Offering expenses         $ 0 (4,000) 0 (4,000)
Balance (in shares) at Jan. 31, 2025         4,264,482      
Balance at Jan. 31, 2025         $ 43,000 $ 138,092,000 $ (125,858,000) $ 12,277,000
[1] Excludes the effect of unvested restricted shares of common stock, which are considered non-participating securities. As of January 31, 2025 and 2024, there were 213,273 and 131,350 unvested restricted shares of common stock, respectively.